Lynnsey and Matthew are joined by Neal Goodwin and Pawel Krysiak of Jaya Bio, a preclinical life sciences company developing gene therapies for genetically defined neurodegenerative diseases. They share how their team is using precision medicine to target specific mutations linked to Alzheimer’s, Parkinson’s, and frontotemporal dementia, aiming to arrest disease progression with a single dose. Our conversation explores how gene therapy works, what makes Jaya Bio’s approach different, and more. Tune in now!
Press CTRL+C to copy embed code to clipboard
